MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, IRM had $2,819K increase in cash & cash equivalents over the period. -$931,629K in free cash flow.

Cash Flow Overview

Change in Cash
$2,819K
Free Cash flow
-$931,629K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from revolving credit f...
    • Net proceeds from sales of senio...
    • Depreciation
    • Others
Negative Cash Flow Breakdown
    • Repayment of revolving credit fa...
    • Capital expenditures
    • Parent cash dividends
    • Others

Cash Flow
2025-12-31
2024-12-31
2023-12-31
2022-12-31
Net income (loss)
152,254 183,666 187,263 562,149
Depreciation
730,885 629,296 525,850 478,984
Amortization (includes amortization of deferred financing costs and discounts of 32,769, 25,580 and 16,859 in 2025, 2024 and 2023, respectively)
326,319 297,189 267,168 266,655
Intangible impairments
---0
Revenue reduction associated with amortization of customer inducements and data center above- and below-market leases
6,151 5,347 7,036 8,119
Stock-based compensation expense
140,280 118,138 73,799 56,861
(benefit) provision for deferred income taxes
-47,682 -41,415 -35,264 -55,920
Loss on early extinguishment of debt
----671
Loss (gain) on disposal/write-down of property, plant and equipment, net
-24,641 -6,196 12,825 93,268
Loss on deconsolidation
-0 0 -105,825
Loss (gain) associated with the remeasurement of deferred purchase obligations
-19,680 -29,498 0 93,600
Gain associated with clutter transaction
---35,821
Loss (gain) associated with the remeasurement to fair value of our previously held equity interest
0 0 -38,000 -
Foreign currency transactions and other, net
48,018 41,191 103,134 20,524
(increase) decrease in assets
262,668 78,282 70,287 224,641
Increase (decrease) in liabilities
202,121 5,884 29,693 -27,795
Cash flows from operating activities
1,339,999 1,196,708 1,113,567 927,695
Capital expenditures
2,271,628 1,791,564 1,339,223 875,378
Cash paid for acquisitions, net of cash acquired
101,625 178,414 41,849 803,690
Acquisition of customer intangibles
75,487 62,386 0 2,143
Customer inducements
--5,874 6,062
Contract costs
-95,924 -112,542 -95,124 -70,336
Net proceeds from ipm divestment
--0 0
Investments in joint ventures and other investments, net
43,177 9,834 15,830 73,233
Proceeds from sales of property and equipment and other, net
13,635 17,979 53,544 170,419
Cash flows from investing activities
-2,574,206 -2,136,761 -1,444,356 -1,660,423
Repayment of revolving credit facility, term loan facilities and other debt
16,003,355 14,473,019 18,191,921 11,593,452
Proceeds from revolving credit facility, term loan facilities and other debt
17,009,781 14,965,010 18,386,168 12,949,766
Early redemption of senior subordinated and senior notes, including call premiums
---0
Net proceeds from sales of senior notes
1,390,651 1,188,000 990,000 0
Equity contributions from noncontrolling interests
93,347 230,814 24,684 29,172
Equity distribution to noncontrolling interests
12,924 2,684 3,855 2,953
Repurchase of noncontrolling interest
0 35,203 400 4,519
Parent cash dividends
919,388 789,527 737,650 724,388
Payment of deferred purchase obligations and other deferred payments
240,680 158,775 --
Net (payments) proceeds associated with employee stock-based awards
36,806 12,197 -8,754 -4,849
Other, net
-12,712 -35,674 -32,606 -9,570
Cash flows from financing activities
1,267,914 876,745 425,666 639,207
Effect of exchange rates on cash and cash equivalents
-30,888 -3,765 -13,885 -20,510
Increase (decrease) in cash and cash equivalents
2,819 -67,073 80,992 -114,031
Cash and cash equivalents at beginning of period
155,716 222,789 141,797 255,828
Cash and cash equivalents at end of period
158,535 155,716 222,789 141,797
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Depreciation$730,885K (16.14%↑ Y/Y)Amortization (includesamortization of deferred...$326,319K (9.80%↑ Y/Y)Increase (decrease) inliabilities$202,121K (3335.10%↑ Y/Y)Net income (loss)$152,254K (-17.10%↓ Y/Y)Proceeds from revolvingcredit facility, term...$17,009,781K (13.66%↑ Y/Y)Stock-based compensationexpense$140,280K (18.74%↑ Y/Y)Foreign currencytransactions and other, net$48,018K (16.57%↑ Y/Y)Loss (gain) ondisposal/write-down of property,...-$24,641K (-297.69%↓ Y/Y)Loss (gain)associated with the...-$19,680K (33.28%↑ Y/Y)Revenue reductionassociated with...$6,151K (15.04%↑ Y/Y)Net proceeds fromsales of senior notes$1,390,651K (17.06%↑ Y/Y)Equity contributionsfrom noncontrolling...$93,347K (-59.56%↓ Y/Y)Cash flows fromoperating activities$1,339,999K (11.97%↑ Y/Y)Cash flows fromfinancing activities$1,267,914K (44.62%↑ Y/Y)Canceled cashflow$310,350K Canceled cashflow$17,225,865K Increase (decrease) incash and cash...$2,819K (104.20%↑ Y/Y)Canceled cashflow$2,605,094K (increase) decrease inassets$262,668K (235.54%↑ Y/Y)(benefit) provision fordeferred income taxes-$47,682K (-15.13%↓ Y/Y)Proceeds from sales ofproperty and equipment...$13,635K (-24.16%↓ Y/Y)Repayment of revolvingcredit facility, term...$16,003,355K (10.57%↑ Y/Y)Parent cash dividends$919,388K (16.45%↑ Y/Y)Payment of deferredpurchase obligations and...$240,680K (51.59%↑ Y/Y)Net (payments)proceeds associated with...$36,806K (201.76%↑ Y/Y)Equity distribution tononcontrolling interests$12,924K (381.52%↑ Y/Y)Other, net-$12,712K (64.37%↑ Y/Y)Cash flows frominvesting activities-$2,574,206K (-20.47%↓ Y/Y)Effect of exchangerates on cash and cash...-$30,888K (-720.40%↓ Y/Y)Canceled cashflow$13,635K Capital expenditures$2,271,628K (26.80%↑ Y/Y)Cash paid foracquisitions, net of cash...$101,625K (-43.04%↓ Y/Y)Contract costs-$95,924K (14.77%↑ Y/Y)Acquisition of customerintangibles$75,487K (21.00%↑ Y/Y)Investments in jointventures and other...$43,177K (339.06%↑ Y/Y)

logo-iron-mountain-2-svg

IRON MOUNTAIN INC (IRM)

logo-iron-mountain-2-svg

IRON MOUNTAIN INC (IRM)